Hosted on MSN14m
Listeria Outbreak From Frozen Shakes Kills 12, Sickens 38
Key Takeaways A listeria outbreak linked to frozen shakes has killed 12 and sickened 38 peopleThe shakes were distributed to ...
Hosted on MSN18m
FDA accepts BMS’ Opdivo-Yervoy combo sBLA for colorectal cancer
The US Food and Drug Administration (FDA) has accepted Bristol Myers Squibb’s (BMS) supplemental biologics licence ...
NBC2636m
Hims and Hers likely to stop selling cheaper versions of GLP-1 medications
The FDA has resolved the shortage of Wegovy and Ozempic, but companies like Hims and Hers may halt sales of compounded versions due to regulatory changes.
Undercurrent News45m
Trump administration rehiring nearly 300 FDA employees, delays ‘healthy’ label implementation
Those rehired by the Trump administration include at least 10 FDA staffers responsible for reviewing the safety of new food ...
STAT52m
Lilly expands its Zepbound vial offering, as Hims pulls back on semaglutide
Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and other biotech news in today's Readout ...
STAT53m
Trump’s FDA navigates layoffs, exits, and a new hire
The Trump administration has started rehiring some of the FDA employees it fired last week, the latest chapter in a haphazard ...
Hims is officially phasing out its copycat weight-loss drugs, and the company's stock tumbled — again
After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop ...